Quarterly report [Sections 13 or 15(d)]

Commitments and Contingencies - Contingent Consideration (Details)

v3.25.1
Commitments and Contingencies - Contingent Consideration (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Apr. 30, 2024
Commitments And Contingencies      
Exarafenib milestone contingent consideration $ 3,307 $ 3,214  
CVR Agreement | Kinnate CVR holders      
Commitments And Contingencies      
Exarafenib milestone contingent consideration $ 3,300   $ 2,900